What are theranostics, and how are they used to treat cancer? With Dr Ashleigh Hull and Dr Stephen Tronchin episode artwork

EPISODE · Apr 29, 2026 · 52 MIN

What are theranostics, and how are they used to treat cancer? With Dr Ashleigh Hull and Dr Stephen Tronchin

from Nuclear Matters

In this episode, Dr Ashleigh Hull and Dr Stephen Tronchin join host Liz Williams to explore theranostics — a cutting-edge approach to cancer treatment that uses radiopharmaceuticals to both detect and treat cancers from within the body. They cover the science behind how these treatments are designed to target cancer cells, which cancers theranostics is already being used for, and the real-world supply chain challenges that determine how many patients can access these therapies. The episode closes with a look at what's on the horizon for the field in Australia and globally.Dr Ashleigh Hull is a nuclear medicine technologist and lecturer in medical physics, and Dr Stephen Tronchin is a post-doctoral research fellow. Both work at Adelaide University and are part of Radinnovate, an Australian Research Council Industrial Transformation Training Center focused on developing the next generation of nuclear and radiation science researchers for Australia.CreditsGuests: Ashleigh Hull, Stephen TronchinHost: Elizabeth WilliamsAudio Producer: Martin Franklin (East Coast Studio)Show notesStephen wanted to clarify that beta particles have a range of 1-10 mm in tissue.Places to study to become a nuclear medicine technologist in AustraliaMines to MedicinesAcknowledgementsThank you to Eva Bezak for introducing me to Ash and Stephen. ANU is one of the university partners involved in Radinnovate.The usual end matterNuclear Matters is a production of the Australian National University College of Systems and Society and the ANU Nuclear Stewardship Network. We acknowledge the Traditional Owners of the lands on which this podcast is being recorded on or listened to, and pay our respects to their Elders – and all First Nations people.If you want to send us some feedback on an episode, email us at [email protected] in mind that this podcast is intended for information and education only. In particular, nothing in this episode is intended to serve as medical advice - please consult a qualified medical practitioner.The views and opinions expressed in each episode are those of the individual speakers and do not represent the official policy or position of the Australian National University College of Systems and Society or the University as a whole.

NOW PLAYING

What are theranostics, and how are they used to treat cancer? With Dr Ashleigh Hull and Dr Stephen Tronchin

0:00 52:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Nuclear Matters?

This episode is 52 minutes long.

When was this Nuclear Matters episode published?

This episode was published on April 29, 2026.

What is this episode about?

In this episode, Dr Ashleigh Hull and Dr Stephen Tronchin join host Liz Williams to explore theranostics — a cutting-edge approach to cancer treatment that uses radiopharmaceuticals to both detect and treat cancers from within the body. They cover...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Nuclear Matters episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!